Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

668 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of e-cigarettes, traditional combustible cigarettes, and high sensitivity C-reactive protein: The Cross Cohort Collaboration.
Yao Z, Tasdighi E, Dardari ZA, Erhabor J, Jha KK, Osuji N, Rajan T, Boakye E, Rodriguez CJ, Lima JAC, Judd SE, Feldman T, Fialkow JA, Vasan RS, El Shahawy O, Benjamin EJ, Bhatnagar A, DeFilippis AP, Nasir K, Blaha MJ. Yao Z, et al. Among authors: feldman t. Am Heart J. 2025 Feb;280:1-6. doi: 10.1016/j.ahj.2024.10.012. Epub 2024 Oct 24. Am Heart J. 2025. PMID: 39461654
Lipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida.
Mszar R, Cainzos-Achirica M, Valero-Elizondo J, Lahan S, Al-Kindi SG, Quispe R, Ali SS, Arias L, Saxena A, Shah SH, Cury RC, Budoff MJ, Blaha MJ, Shapiro MD, Sharma G, Santos RD, Blankstein R, Feldman T, Fialkow J, Nasir K. Mszar R, et al. Among authors: feldman t. Circ Cardiovasc Imaging. 2024 Jul;17(7):e016152. doi: 10.1161/CIRCIMAGING.123.016152. Epub 2024 Jul 16. Circ Cardiovasc Imaging. 2024. PMID: 39012945
Modeling, synthesis and cell-based evaluation of pyridine-substituted analogs of CD3254 and fluorinated analogs of CBt-PMN as novel therapeutics.
Jurutka PW, Khan Z, Kaneko I, Sausedo MA, Shahani PH, MacNeill M, Grozic A, Bhogal J, Swierski J, Wentzel MR, Chhun C, Applegate MT, Raban S, Ibrahim S, Alwaeli K, Feldman TL, Pomeroy KJ, Sarnowski JT, Nguyen N, Ziller JW, Ma N, van der Vaart A, Hackney JF, Marshall PA, Wagner CE. Jurutka PW, et al. Among authors: feldman tl. Bioorg Med Chem. 2025 Jan 2;119:118059. doi: 10.1016/j.bmc.2024.118059. Online ahead of print. Bioorg Med Chem. 2025. PMID: 39808894
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.
Foss FM, Kim YH, Prince HM, Akilov OE, Querfeld C, Seminario-Vidal L, Fisher DC, Kuzel TM, Yannakou CK, Geskin LJ, Feldman T, Sokol L, Allen PB, Dang NH, Cabanillas F, Wong HK, Ooi CE, Xing D, Sauter N, Singh P, Czuczman M, Duvic M. Foss FM, et al. Among authors: feldman t. J Clin Oncol. 2024 Dec 19:JCO2401549. doi: 10.1200/JCO-24-01549. Online ahead of print. J Clin Oncol. 2024. PMID: 39700456
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.
Torka P, Feldman T, Savage KJ, Ganesan N, Drill E, Hancock H, Davey T, Perez L, Capadona C, Subzwari S, Galasso N, Yang J, Post M, Boardman A, Caron P, David K, Epstein-Peterson Z, Falchi L, Ghione P, Hamlin P, Horwitz SM, Intlekofer AM, Johnson W, Kumar A, Lue J, Noy A, Owens C, Palomba ML, Salles GA, Steiner R, Stuver R, Vardhana S, Yahalom J, Dogan A, Zelenetz AD, Schöder H, Moskowitz AJ. Torka P, et al. Among authors: feldman t. J Clin Oncol. 2024 Dec 11:JCO2401278. doi: 10.1200/JCO-24-01278. Online ahead of print. J Clin Oncol. 2024. PMID: 39661923
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma.
Lee HJ, Ramchandren R, Friedman J, Melear J, Flinn IW, Burke JM, Linhares Y, Gonzales P, Peterson M, Raval M, Chintapatla R, Feldman TA, Yimer H, Islas-Ohlmayer M, Patel A, Metheny L, Dean A, Rana V, Gandhi MD, Renshaw J, Ho L, Fanale MA, Guo W, Yasenchak CA. Lee HJ, et al. Among authors: feldman ta. Blood. 2025 Jan 16;145(3):290-299. doi: 10.1182/blood.2024024681. Blood. 2025. PMID: 39622165 Clinical Trial.
Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530].
Lurain K, El Zarif T, Ramaswami R, Nassar AH, Adib E, Abdel-Wahab N, Chintapally N, Drolen CE, Feldman T, Haykal T, Nebhan CA, Kambhampati S, Li M, Mittra A, Lorentsen M, Kim C, Drakaki A, Morse M, Johnson DB, Mangla A, Dittus C, Ravi P, Baiocchi RA, Chiao EY, Rubinstein PG, Yellapragada SV, LaCasce AS, Sonpavde GP, Naqash AR, Herrera AF. Lurain K, et al. Among authors: feldman t. Clin Lymphoma Myeloma Leuk. 2024 Dec;24(12):873. doi: 10.1016/j.clml.2024.10.011. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39603773 No abstract available.
668 results